UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

This creates a rare market asymmetry: The public sees "bubble" and flees everything AI-related, while sophisticated capital is making precise bets on deflation survivors. Here are three investment ...

UiPath's strategy reflects a company that's no longer chasing automation hype -- it's laying the groundwork for durable, ...

The stock market is booming, but there are still bargains to be found. Long-term investors who are ready to commit $1,000 to ...

UiPath (PATH) shares climbed higher recently, continuing a steady uptrend seen over the past month. The stock has delivered a 42% gain in that period, prompting more investors to take a closer look at ...

What we really do is we took the most constrained, complex, and costly medical imaging solution in radiology, and we ...

UiPath 's ( PATH +2.93%) business centers around automating and leveraging artificial intelligence (AI) to save users time.

If you're looking for companies quietly shaping the next wave of AI-driven productivity, UiPath deserves a closer look.

The standing of UiPath among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ...

Evidence presented in a new Public Accounts Committee report covering smart public services delivery suggests a change in tack is needed ...

Daniel Dines, CEO and Chairman of UiPath ( PATH +2.93%), sold 122,734 shares for $2,254,881.32 on October 10, 2025. Dines ...